---
title: Intervention in Single Thyroid Nodule.
nct_id: NCT05658809
overall_status: UNKNOWN
phase: NA
sponsor: Assiut University
study_type: INTERVENTIONAL
primary_condition: Thyroid Nodule
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT05658809.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT05658809"
ct_last_update_post_date: 2022-12-21
last_seen_at: "2026-05-12T07:24:14.285Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Intervention in Single Thyroid Nodule.

**Official Title:** Total Thyroidectomy Versus Hemithyroidectomy for Patients With Single Thyroid Nodule , Prospective Comparative Study

**NCT ID:** [NCT05658809](https://clinicaltrials.gov/study/NCT05658809)

## Key Facts

- **Status:** UNKNOWN
- **Phase:** NA
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 40
- **Lead Sponsor:** Assiut University
- **Conditions:** Thyroid Nodule
- **Start Date:** 2022-12-30
- **Completion Date:** 2023-12-30
- **CT.gov Last Update:** 2022-12-21

## Brief Summary

Thyroid nodules are common clinical problem. The incidence is 2-4 per 100,000 people per year, being more common in women and the elderly. thyroid nodule is a "discrete lesion within the thyroid gland that is radiologically distinct from the surrounding thyroid parenchyma. Most thyroid nodules are asymptomatic, may present as neck swelling

## Detailed Description

Thyroid nodular disease comprises of a wide range of disorders. Benign forms such as colloid nodules,cysts and thyroiditis are more comman than benign follicular neoplasms and thyroid carcinomas. Incidence of malignancy ranges from 10% to 30% in solitary thyroid nodule(STN).Studies have shown that the occurrence of malignancy is higher in case of solitary thyroid nodule compared to multinodular goitres. Preoperative evaluation of thyroid nodules is important in distinguishing between benign and malignant thyroid nodules and also in treatment to avoid unnecessary extensive surgery and its complications. Fine needle aspiration biopsy (FNAB) is the most common method of examining solitary thyroid nodules today.Total thyroidectomy and lobectomy remain the main primary surgical interventions for single thyroid nodule. There is debat between total thyroidectomy and hemithyroidectomy for patients with single thyroid nodule. our study is for comparing between total thyroidectomy and hemi thyroidectomy in single thyroid nodule

## Eligibility

- **Minimum age:** 20 Years
- **Maximum age:** 60 Years
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

1. Age from 20 to 60 years.
2. patients with single thyroid lesion
3. Fit for surgery

Exclusion Criteria:

1. patients with age less than 20 years and more than 60 years.
2. patients with multiple thyroid lesions.
3. patients with advanced and metastatic malignancy.
4. Unfit for surgery
```

## Arms

- **Total thyroidectomy for single thyroid nodule** (ACTIVE_COMPARATOR) — group of participants will be treated with total thyroidectomy
- **Hemithyroidectomy for single thyroid nodule** (ACTIVE_COMPARATOR) — 2nd group of participants will be treated with hemithyroidectomy

## Interventions

- **thyroidectomy** (PROCEDURE) — Patients will be divided into 2 groups group will be treated with total thyroidectomy and the other group will be treated with hemithyroidectomy

## Primary Outcomes

- **Improvement in the management of single thyroid nodule to reduce the morbidity and mortality rates** _(time frame: one year)_ — Compare between total thyroidectomy and hemithyroidectomy in patients with single thyroid nodule to improve the management of single thyroid nodule in general surgery department , Assiut university hospital.

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.maxAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT05658809.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT05658809*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*